that’s pretty much my thoughts as well. I would think that IF...

that’s pretty much my thoughts as well. I would think that IF all the milestones are hit and commercialisation doesn’t through any major X factors, such as a supply halt on a critical part of the equipment etc, and hospitals etc all take up a new technology over existing equipment (that’s probably the major stumbling block) then somewhere around $7-$10 per share is very achievable. So a market cap of about $500m providing all things align.

I don’t own ZNO or really any of the other exciting share price stories out there at the moment. I’m pretty boring in what I buy so I see EMV as a great speculative investment. If there’s any doubt about “speculative” then you need to check with an accountant as to what that means. The key risks aren’t too high for EMV and Australia has a good track record with these sorts of companies, CSL COH and RMD being the obvious leading lights. I think EMV looks pretty good but I’m sticking to only 1% portfolio weight for now.